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ABSTRACT
Objective: Lipid profile is matter to concern in fast changing lifestyle, and especially in diabetic mellitus (DM) patients. In arena of DM, obesity and 
high lipid contour is a causative problem and lead to generate the related problems too. Hence, tracking of lipid profile in DM patients is necessary 
as part of treatment approach. Hence, the present study was conducted to track the effect of Lodhradi Kashaya spray dried (LKSD) powder on lipid 
profile in Type 2 DM patients.
Methods: Total 31 patients were taken following the guideline mention in Central Council for Research in Ayurveda and Siddha protocol for DM 
research. They were divided into two groups, Groups A and B and given LKSD (4 and 2 g TDS (three times a day), respectively, dissolved in water) for 
3 months. They are investigated for their blood serum creatinine and lipid profile (cholesterol, low-density lipoprotein [LDL], high-density lipoprotein 
[HDL], very LDL [VLDL], and triglyceride). The patients response has also been noted regarding palatability acceptance and ease of administration.
Result: LKSD was found significantly effective in total cholesterol (p=0.001 and 0.073), triglyceride (p=0.002 and 0.003), HDL (p˂0.001 and 0.026), 
LDL (p=0.563 and p˂0.001), and VLDL (p=0.024 and 0.003). Patients had reported that formulation is easy to take in spite of its astringency in taste.
Conclusion: Lodhradi Kashaya has capability to control and take care of disturbance in lipid profile in DM patients and thus enhance their living 
confidence.
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INTRODUCTION
Lipid profile is considered as outcome of disturbed metabolism and 
improper lifestyle. It is also causative factor for many of ailments and 
complications in the body as well as it also being worst in a progressive 
manner in case of metabolism related disease like diabetes mellitus (DM). 
Diabetes is characterized by chronic hyperglycemia and disturbances 
of carbohydrate, lipid and protein metabolism. On the other hand, 
obesity is important preventable cause of death global, with increasing 
prevalence in adults and children, and authorities view it as one of the 
most serious public health diseases of the 21st century. According to 
the WHO global estimates, about 13% of the world’s adult population 
(11% of men and 15% of women) was obese in 2014 [1]. A positive 
association between obesity and the risk of developing noninsulin-
dependent diabetes mellitus (NIDDM) has been repeatedly observed in 
both cross-sectional [2] and prospective studies [3]. The consistency 
of the association across populations despite difference measures of 
fatness and criteria for diagnosing NIDDM reflects the strength of the 
relationship, i.e., the risk of NIDDM increases continuously with body 
mass index (BMI) and decreases with weigh loss [4].
It has been established that DM patients have more prone to develop 
hyperlipidemia. Their physiology responded to decrease high-density 
lipoprotein (HDL), increase low-density lipoprotein (LDL), very 
LDL (VLDL), and triglyceride. Hyperlipidemia predisposes premature 
atherosclerosis and macrovascular complication too [5].
Insulin resistance and Type 2 diabetes are associated with a clustering of 
interrelated plasma lipid and lipoprotein abnormalities, which include 
reduced HDL-cholesterol (HDL-C), a predominance of small dense LDL 
particles, and elevated triglyceride levels. In fact, prediabetic individuals 
often exhibit an atherogenic pattern of risk factors that includes higher 
levels of total cholesterol, LDL cholesterol, and triglycerides, and lower 
levels of HDL-C than individuals who do not develop diabetes [6]. The 
prevalence of dyslipidemia in DM patients is 95%. It is also a major 
risk factor for coronary heart disease (CHD). Cardiovascular disease 
is a cause of morbidity and mortality in patients with DM because 
of disturbance in lipoproteins, i.e., serum triglycerides 69%, serum 
cholesterol 56.6%, LDL 77%, and HDL 71% [7,8]. Hence, tracking of 
lipid profiles along with blood sugar level is becoming more important 
parameter in treatment approach. Hence, an ayurvedic formulation has 
been taken for study its role in DM as it was said “Madhumehajeet” in 
Basavarajiyam. The same formulation also has been dictated in Charak 
Samhita and Vaidya Chintamani under Prameha Prakaranam. In present 
clinical assessment, our main focus to see pattern of lipid profile during 
treatment with Lodhradi Kashaya spray dried (LKSD). Ingredients of 
LKSD (Table 1) have also separately reported for hypolipidemic action 
or for reducing obesity in contemporary research, and thus we analyzed 
here about their role in controlling lipid profile in Type 2 DM patients.
METHODS
Study design
Total 36 patients were registered for a clinical trial at outpatient 
department, Indian Medicine Wing, Sir Sunderlal Hospital, Banaras 
Hindu University, Varanasi in which 5 patients were dropped out. 
Inclusion criteria for selection of diabetic patients of either sex, 
age group of 30-70 years, 8 hrs fasting blood sugar (FBS) >126 and 
<250 mg/dl and 2 hrs postprandial blood sugar >200 to <350 mg/dl. 
We had excluded the patients not lying in the parameter of inclusion 
criteria and patients suffering from retinopathy, nephropathy, 
cardiovascular problems, hormonal imbalance, regnant, and lactating 
mother. Their lipid profile has been investigated at starting and end of 
the study (3 months duration). We have followed the protocol of Central 
Council for Research in Ayurveda and Siddha for DM [9] with little 
modification. This clinical study has been registered in Institutional 
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Ethical Committee, Institute of Medical Sciences, Banaras Hindu 
University as “ECR/526/Inst./UP/2014.”
Trial drugs
For this study, Lodhradi Kashaya has been made available to patients 
as LKSD powder. For this purpose, we have modified the Kashaya 
(decoction) form into powder dosage form, using spray drier technology 
at Sanat Products Ltd., Sikandrabad, Noida, Uttar Pradesh [10]. To 
maintain its quality and reproducibility, LKSD was standardized on 
several parameters [11]. To ensure the administration of LKSD as 
Kashaya, it was strictly recommended to dissolve unit dose it into 
lukewarm water to make Kashaya like form.
Patients grouping
Total 31 patients were divided into two group, Groups A and B having 
14 patients and 17 patients, respectively. Group A (patients having FBS 
more than 160) was given a dose of 4 g total dissolved solids (TDS) 
while Group B (patients having FBS <160) was given 2 g TDS of Lodhradi 
Kashaya powder. The patients were strictly advised to dissolve unit 
dose of powder into 100 ml lukewarm water just before administration 
and drink it. Patients are advised to do regular exercise and diet control 
as prescribed to avoid high sugar and fat content diet. Patients are also 
advised to examine lipid profile and council to take Lodhradi Kashaya 
in proper manner.
Statistical analysis
Findings were analyzed statistically by SPSS 16.00 version applying 
the paired t-test, one-way ANOVA, Friedman test, and Chi-square test. 
The results are interpreted with possible co-relation of ayurvedic 
and contemporary point of view. p<0.05 was considered statistically 
significant and p<0.001 was considered highly significant in the results 
of this study.
RESULT
All the patients were selected independently of their sex, age, caste, 
economy, and religions. Total 36 patients were registered while 5 have 
left the study due to their own consent. The patients variable and their 
profile were given in Table 2. In this patient distribution, it was seen 
that male patients are more in number with age group of 40-70 years. In 
patients, it was observed that most of the patients do not have a diabetic 
history in family and BMI more than 25 had showed strong presence 
in distribution. In this study, when we analyzed the lipid profile of the 
patients, LKSD was found significantly effective in total cholesterol 
(p=0.001 and 0.073), triglyceride (p=0.002 and 0.003), HDL (p˂0.001 
and 0.026), LDL (p=0.563 and ˂0.001), and VLDL (p=0.024 and 0.003) 
for Groups A and B, respectively (Tables 3 and 4). Patients had reported 
that formulation is easy to take in spite of its astringency in taste.
DISCUSSION
Peoples around the world are bending toward herbal medicines as they 
suppose it biological and medicinal activities, higher safety margins, 
consumer own interest and reasonable cost for long-term use, and 
to avoid long-term adverse drug reactions. In the market, consumers 
are looking for natural ingredients in food, drugs and cosmetics as 
they believe that anything natural will be more safe and devoid of side 
effects [12]. Ayurveda also have upper hand in service of humanity with 
ingredients from natural resources as well as recognition of prediabetes 
stage described in ayurvedic science such as knotted hair, burning 
sensation, numbness, sweetness in mouth, laziness, body odor like fish 
whereas modern science has no such criteria. DM is due to increase in 
vata caused by either blockage of strota (body channel) by aggravated 
kapha and medodhatu or due to mental stress, food habit, lifestyle, 
etc. [13] which can be co-related that high BMI and obesity in patients 
were reason behind DM. In low BMI patients, improper metabolism 
as well as malfunctionality of pancreas is also reason for DM. Here a 
formulation, Lodhradi Kashaya (Table 1) was selected for study having 
natural ingredients from arena of ayurvedic wisdom as it was dictated 
as ‘Madhumehajeet (winner of DM)’ in Basavarajeeyam and the same 
formulation was also mentioned in Vaidya Chintamani and Charaka 
Samhita too [14,15]. This formulation was indicated to take as Kwath 
form (decoction), so here we made an attempt to modify the dosage 
form as LKSD powder which was indicated to dissolve into lukewarm 
water just before administration so that we can stick to fundamental 
prescribed dosage form while validating the ancient wisdom. Kashaya 
was indicated to take in 2 pala (Sharangdhar Samhita) or 1 pala (Yadav 
ji Tikram Ji) in divided dose while in the Ayurvedic Pharmacopoeia of 
India suggest to take kashaya obtained from 48 g of Kwath churna. If we 
make Kwath and dry it, then we gat yield of about 12 g (2 pala Kwath) 
and 6 g (1 pala Kwath) in a day. So on this basis two doses, i.e., 4 g TDS 
and 2 g TDS dose has been decided for human being. Patients were 
grouped into A (FBS ≥160) and B (FBS ˂ 160) were given treatment with 
4 g TDS and 2 g TDS, respectively. So ancient wisdom always talks about 
management of disease not only targeting the hypoglycemic action but 
also on other factors such as lipid profile and liver profile.
In presented clinical study, total 31 diabetic patients were registered for 
the study of effect of Lodhradi Kashaya on their diabetic profile including 
lipid profile in them. They are divided into Groups A and B based on 
their diabetic intensity (Table 2), i.e., patients having FBS >160 are 
placed in Group B while FBS below 160 were placed in Group B. Blood 
sugar, hemoglobin A1C, and liver function test profile were improved 
significantly during course of treatment with LKSD [16]. Hence here, 
lipid profile was focused to know the variation in them. Lipid profile 
was assessed at starting of study (0 day) and end of study (90 days) 
by assessing five parameters, viz., total cholesterol, triglyceride, HDL, 
Table 1: Ingredients of Lodhradi Kashaya
Serial Plant Botanical name Family Part used Ratio
1 Lodhra Symplocos racemosa Roxb. Symplocaceae Stem bark 1 part
2 Haritaki Terminalia chebula Retz. Combretaceae Fruit pulp 1 part
3 Musta Cyperus rotundus Linn. Cyperaceae Rhizome 1 part
4 Katphala Myrica nagi Linn. Myricaceae Stem bark 1part
Table 2: Patients distribution and variables








Number of patients Total 14 17










Diet Vegetarian 57.1 29.4
Mixed 42.9 70.6
Addiction Tobacco 35.7 11.8
Smoking 14.3 0
Alcohol 7.1 0
BMI ≤18 0 0
≥18 to≤24.9 21.42 41.17
≥25 78.57 58.82
BMI: Body mass index
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LDL, and VLDL. The association between lipid profile and body fat 
distribution has been much discussed during the past decades.
Both lipid profile and body fat mass have been shown to be the 
important predictors for metabolic disturbances and serious 
medical conditions, including dyslipidemia, hypertension, diabetes, 
cardiovascular diseases, among other [17,18]. Lipid abnormalities 
are common in diabetics and frequently seen in type 2 diabetics. 
Dyslipidemia make diabetics prone to develop CHD and other 
complications of atherosclerosis. This variation in lipid profile of DM 
patients in prevalence may be due to differences in BMI and possibly 
genetic variation. In diabetes many factors may affect blood lipid 
levels, because of interrelationship between carbohydrates and lipid 
metabolism. Therefore, any disorder in carbohydrate metabolism 
leads to disorder in lipid metabolism and vice versa [19]. In this study, 
LKSD significantly reduces the total cholesterol (Table 3) in Group A 
(t=4.48, p=0.001), while in Group B decrease is not significant 
(t=1.91; p=0.073). Overall in both groups total cholesterol amount 
was decreased; thus we can say that LKSD is effective more in case 
A. In higher dose of LKSD (4 g TDS), it is significantly effective in 
reducing cholesterol level. This may be due to that, patient criteria 
of grouping affect the extent of reduction. In Group A, the patients 
(FBS above 160) are developing more abnormalities thus producing 
more total cholesterol that are controlled by the higher dose in 
presented study. Lodhradi Kashaya also significantly reduced the 
level of triglyceride in both Groups A and B patients (Table 3). 
However, it was found more significant in Group B (t=3.72, p=0.002) 
in comparison of Group A (t=3.56, p=0.003). HDL so called good 
cholesterol, acts by enhancing the removal of cholesterol from the 
peripheral tissues and so reduces the body’s cholesterol pool. Type 2 
DM was usually associated with low plasma levels of HDL, and there 
were also lower mean HDL concentrations in hypertensive type 2 
diabetic males and hypertensive type 2 diabetic females. Low HDL-C 
concentrations are often accompanied by elevated triglyceride levels. 
The denser LDL particles acquire a large proportion of these HDL 
esters, further diminishing the HDL and decrease its level [20]. HDL 
is decreased due to an abnormality in digestion and metabolism 
and due to defect in metabolic reactions. HDL level was increased 
significantly in both groups treated with LKSD (Table 4). Increase in 
HDL was found highly significance Group A (t=−5.14, p˂0.001), while 
in Group B increase was found significant (t=−2.45, p=0.026). LDL was 
found to decrease nonsignificantly in Group B (t=0.591, p=0.563) and 
significantly in Group A (t=5.46, p˂0.001). However, if it was analyzed, 
then it shows that LKSD decreases LDL in all the diabetic patients 
(Table 4). The result was found highly significant in the higher dose 
(4 g TDS) which indicate that it was more effective when given in 
higher dose with the association between elevated blood glucose 
concentrations and low concentrations of HDL. Hyperglycemia 
progressively increases the transfer of cholesterol esters from HDL to 
VLDL particles. LKSD was found effective in lowering the VLDL during 
the study in DM patients, and found significant in both Groups A and 
B (Table 4). Among them, LKSD was found more effective in Group B 
(t=2.48, p=0.024), in comparison to Group A (t=3.61, p=0.003). Since, 
ingredients of LKSD (Table 1), i.e., Lodhra [21], Musta, Katphala, and 
Haritaki have well-established evidence of hypolipidemic action and 
hepatoprotective. These actions may be due to phytoconstituents 
such as tannins, polyphenols, saponins, and many other antioxidants 
in the formulation. Saponin modulates the expression of many genes 
associated with lipid metabolism and hence regulates hyperlipidemia 
associated with diabetes by: (a) Modulation of leptin, adiponectin, as 
well as the inhibition of insulin resistance (b) enhancing the expression 
of peroxisome proliferator-activated receptor a key transcriptional 
factor in adipogenesis regulation, (c) reduction of triglyceride, and 
(d) reduction of serum cholesterol. Phenolic compounds have been 
attributed to induction of β-cell regeneration and a direct action on 
adipose cells all these phytoconstituents are collectively responsible 
for overall effect of LKSD on lipid profile in DM patients [22].
CONCLUSION
When we look on scenario of diabetic patients and compare the reason 
behind it as well as several complications arises after it, then, we found 
that lipid profile is very important factor to look out and need attention. 
Lodhradi Kashaya was mentioned century years before in Charaka 
Samhita, Vaidya Chintamani and Basavarajeeyam for the management 
of Prameha, and Madhumeha. In the 21st century Lodhra, Musta, 
Katphala, and Haritaki are widely reported for hypolipidemic action. 
In this study, Lodhradi Kashaya was found effective in controlling the 
disturbance in lipid profile of diabetic patients thus encouraging to do 
more work in this direction.
Table 3: Effect of LKSD on total cholesterol and triglyceride
Groups Total cholesterol Triglyceride
0 day 90 days Within the group
Paired t‑test 0‑90 days
0 day 90 days Within the group
Paired t‑test 0‑90 days








LKSD: Lodhradi Kashaya spray dried
Table 4: Effect of LKSD on HDL, LDL, and VLDL
Group Mean±SD
HDL LDL VLDL
0 day 90 days Within the 
group
Paired t‑test
0 day 90 days Within the 
group
Paired t‑test
















LDL: Low-density lipoprotein, HDL: High-density lipoprotein, VLDL: Very low-density lipoprotein, LKSD: Lodhradi Kashaya spray dried
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